---
title: Blood-Based Biomarkers for Early Alzheimer's Disease Diagnosis in Real-World
  Settings
date: '2024-03-01'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38427184/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240302170447&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: As our knowledge about the biology of Alzheimer's disease (AD) expands
  and we recognize the significance of early intervention for effective treatment,
  there is a shift in focus toward detecting the disease at an early stage. AD is
  characterized by the accumulation of misfolded amyloid-β (Aβ) and phosphorylated
  tau proteins in the brain, leading to the formation of senile plaques and neurofibrillary
  tangles. While a definitive diagnosis of AD can only be confirmed through autopsy
  by ...
disable_comments: true
---
As our knowledge about the biology of Alzheimer's disease (AD) expands and we recognize the significance of early intervention for effective treatment, there is a shift in focus toward detecting the disease at an early stage. AD is characterized by the accumulation of misfolded amyloid-β (Aβ) and phosphorylated tau proteins in the brain, leading to the formation of senile plaques and neurofibrillary tangles. While a definitive diagnosis of AD can only be confirmed through autopsy by ...